Alumni

San Francisco, US · 1 known investors

Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer. The San Francisco-based company works upstream in the cell and gene therapy discovery process and was acquired by Johnson & Johnson.

AI & Machine LearningBiotechHealthtech